Immunological responses to nasal delivery of free and encapsulated tetanus toxoid: Studies on the effect of vehicle volume

International Journal of Pharmaceutics

Volumn 189, Issue 1, 1999, Pages 75-79

  Eyles, Jim E ^a   Williamson, E Diane ^b   Alpar, H Oya ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

Intranasal; M cells; Microparticles; Mucosal immunization; Nasal associated lymphoid tissues; Vaccines

Indexed keywords

MICROSPHERE; POLYLACTIDE; TETANUS TOXOID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSE; ENCAPSULATION; FEMALE; IMMUNE RESPONSE; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUSPENSION;

ADMINISTRATION, INTRANASAL; ANIMALS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; FEMALE; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICROSPHERES; SOLUTIONS; TETANUS TOXOID; TISSUE DISTRIBUTION;

EID: 0032846448     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00239-2     Document Type: Article

References (15)

1. Almeida A.J., Alpar H.O. Nasal delivery of vaccines. J. Drug Targeting. 3:1996;455-467.
2. Almeida A.J., Alpar H.O., Brown M.R.W. Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs. J. Pharm. Pharmacol. 45:1993;198-203.
3. Alpar H.O., Almeida A.J., Brown M.R.W. Microspheres absorption by the nasal mucosa of the rat. J. Drug Targeting. 3:1994;147-149.
4. Conway B.R., Eyles J.E., Alpar H.O. A comparative study on the immune responses to antigens in PLA and PHB microspheres. J. Controlled Release. 49:1997;1-7.
5. Eyles J.E., Sharp G.J.E., Williamson E.D., Spiers I.D., Alpar H.O. Intranasal administration of poly lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse. Vaccine. 16:1998;698-707.
6. Florence A.T. Oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm. Res. 14:1997;259-266.
7. Giannasca P.J., Boden J.A., Monath T.P. Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell directed lectins. Infect. Immun. 65:1997;4288-4298.
8. Heritage P.L., Underdown B.J., Arsenault A.L., Snider D.P., McDermott M.R. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches. Am. J. Respir. Crit. Care Med. 156:1997;1256-1262.
9. Lemoine D., Francotte M., Preat V. Nasal vaccines from fundamental concepts to vaccine development. Stp Pharma Sci. 8:1998;5-18.
10. Neutra M.R., Pringault E., Kraehenbuhl J-P. Antigen sampling across epithelial barriers and induction of mucosal immune responses. Annu. Rev. Immunol. 14:1996;275-300.
11. Perry M., Whyte A. Immunology of the tonsils. Immunol. Today. 19:1998;414-421.
12. Ridley Lathers D.M., Gill R.F., Montgomery P.C. Inductive pathways leading to rat tear IgA antibody responses. Invest. Ophthalmol. Vis. Sci. 39:1998;1005-1011.
13. Siminia T., Van der Brugge-Gamelkoorn G.J., Jarissen S.H.M. Structure and function of bronchus-associated lymphoid tissue (BALT). Crit. Rev. Immunol. 7:1989;119-150.
14. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.T., Goeke N.M., Olson B.J. Measurement of proteins using bicinchoninic acid. Anal. Biochem. 150:1985;76-85.
15. Spit B.J., Hendriksen E.G.J., Bruijntjes J.P., Kuper C.F. Nasal lymphoid tissue in the rat. Cell Tissue Res. 255:1989;193-198.